WHAT'S KNOWN ON THIS SUBJECT: Significant variation in the mortality of preterm infants has been observed among NICUs. Factors explaining this variation have been difficult to identify.
RESULTS: Early and in-hospital mortality rates among centers were 5% to 36% and 11% to 53% for all GAs, 13% to 73% and 28% to 90% for GAs ,25 weeks, and 1% to 11% and 7% to 26% for GAs $25 weeks, respectively. Center intervention rates significantly predicted both early and in-hospital mortality for infants ,25 weeks. For infants $25 weeks, intervention rates did not predict mortality. The variance in mortality among centers was significant for all GAs and outcomes. Center use of interventions and patient risk factors explained some but not all of the center variation in mortality rates.
CONCLUSIONS:
Center intervention rates explain a portion of the center variation in mortality, especially for infants born at ,25 weeks' GA. This finding suggests that deaths may be prevented by standardizing care for very early GA infants. However, differences in patient characteristics and center intervention rates do not account for all of the observed variability in mortality; and for infants with GA $25 weeks these differences account for only a small part of the variation in mortality. Pediatrics 2013;132:e175-e184 Both patient factors (eg, gestational age [GA] ) and preventive or therapeutic interventions (eg, antenatal corticosteroids) are known to affect the mortality risk of very preterm infants. 1 The hospital in which care is provided also affects mortality risk. Variability in mortality rate by center has been observed in several populations and networks. [2] [3] [4] [5] [6] [7] Two factors may contribute to these center differences: (1) the inherent risk of the patient population served by a center and (2) the patient care delivered at the center. Existing models to predict neonatal mortality at birth are based on individual patient characteristics surrounding birth. 1, [8] [9] [10] [11] These models are useful in providing outcome benchmarks and have been modified as clinical care has improved. They do not, however, adequately address the center effect on outcome. Variation in the patient populations accounts for some but not all of the differences in mortality among centers. 12, 13 Examining the effect of center on the mortality of extremely low birth weight (ELBW; #1000 g) infants may yield insights into ways to improve neonatal care.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network (NRN), a consortium of universityaffiliated NICUs, has maintained a data registry of extremely premature infants using standard data collection and follow-up assessment methods since 1986. This data set allows examination of the variation in neonatal practice and outcomes among academic medical centers. It provides an opportunity to examine possible explanations for the center effect on mortality while controlling for infant and maternal characteristics. In this study, we estimated the variability of ELBW mortality among NRN centers. We assessed the effect of the rates at which centers use certain interventions on this variability in mortality, while adjusting for the effects of patient risk factors known to influence mortality.
METHODS
Eligible infants from all NRN centers were identified, and patient risk factors and center intervention rates were extracted from records of neonatal and maternal characteristics and interventions available in the NRN registry. These variables were used to build models designed to predict mortality outcomes. Early mortality (#12 hours) and in-hospital mortality were analyzed separately, first for all infants and then for 2 subgroups of infants, those with GA ,25 weeks and those with GA $25 weeks.
Data Source
Infants born at NRN centers in 2006-2009 with birth weight of 401 to 1000 g and GA of 22 (0/7) through 28 (6/7) weeks were included. Infants with syndromes or major malformations were excluded. The final data set consisted of 5418 infants from 16 centers. NRN membership did not change during the period of study, 2006-2009.
The NRN ELBW patient registry was approved by the institutional review board at each participating site. Trained research personnel collected maternal, pregnancy, delivery, and infant data as well as morbidity and intervention data from birth until hospital discharge, death, or 120 days of age if still hospitalized. Hospital death after 120 days or survival to discharge was obtained for infants who were hospitalized for longer periods. Definitions for maternal and infant characteristics and interventions were predetermined and described in the manual of operations. GA was determined as the best obstetric estimate on the basis of the mother' s last menstrual period and fetal ultrasonography. Patient risk factors and interventions were obtained from individual patient records. Center intervention rates were calculated from the patient data within a given center.
Outcomes
The 2 main outcomes examined in this study were mortality in the first 12 hours after birth (early mortality) and mortality before discharge (in-hospital mortality). These outcomes were not mutually exclusive, because in-hospital mortality included those infants who died early. Deaths that occurred in the delivery room were included in these mortality outcomes. These outcomes were additionally examined in 2 subgroups of patients, those with GA ,25 weeks and those with GA $25 weeks. The rationale behind testing in these subgroups was that centers or individual physicians within centers may have different policies regarding the resuscitation of infants born at ,25 weeks. We assumed that infants born at $25 weeks' GA were likely to receive aggressive obstetric and neonatal care, whereas infants born before 25 weeks might have had less aggressive care before and after birth. 14 
Patient Risk Factors
Patient risk factors used in this study included mother' s educational level (less than versus high school diploma or higher), private health insurance coverage, prenatal care utilization, gender of the infant, race, ethnicity, birth weight, gestational age, 5-minute Apgar score (,5 vs $5) , and multiple birth (versus single birth). Individual birth weights and gestational ages were expressed as differences from local NICU means.
Center Intervention Rates
Interventions available in the NRNregistry that may be related to mortality were included in the analysis. 
Statistical Analysis
Multilevel hierarchical models were used toevaluatecenterdifferencesinmortality and to evaluate 2 major sources of variation that might explain differences in mortality among centers: patient risk factors and center intervention rates. The assessment of center intervention rates by the presence or absence of patient-level risk factors in a hierarchical model was conducted by using 4 models ( Table 1 ). The derivation and underlying assumptions of the models are described in Appendix 1.
Each model yields an estimated parameter that measures the average center mortality (in log odds terms) and the mortality variance, an estimate ofthe magnitude of variation or dispersion in center mortality. An estimated mortality variance significantly greater than zero indicates variation in mortality among centers that is unlikely to have occurred by chance alone. A decrease in the variance estimates from models with, to those without, center intervention rates indicates the degree to which these interventions explain the center difference in mortality. By using principal components analysis, all center intervention rates were assigned appropriate weights and combined into a single center intervention score for inclusion in the final models. Principal components analysis allowed this to be accomplished despite the collinearity (ie, high correlation between independent variables) among intervention rates. A technical description of the principal components analysis is provided in Appendix 2 and Appendix Table. The clinical implications of these models, ie, theirability to explain center variation in mortality rate, are described below.
Model 1: Intercept Only
This baseline reference model includes center mortality data and is used to assess the level of and variation in overall center mortality but does not include patient risk factors or the intervention score.
Model 2: Center Intervention Rates
This model extends Model 1 by adding the center intervention score as a predictor of mortality to assess the extent to which variation of center mortality can be explained by center intervention rates. Compared with Model 1, the decrease in the estimated mortality variance provides a measure of overall center mortality that can be explained by intervention rates, without correcting for patient population.
Model 3: Patient-Level Risk Factors
This model includes only infant and maternal characteristics. It is used to assess the magnitude of center variation in mortality while controlling for infant and maternal characteristics. Models 3 and 4 can be compared directly only with each other and not with Model 1 or 2.
Model 4: Patient Risk Factors and Center Intervention Rates
This model extends Model 3 by adding the center intervention score as a predictor of center mortality and includes covariates of the infant and maternal characteristics. This model is used to assess the effect of the intervention rates on center mortality after controlling for patient-level risk factors. A decrease in the mortality variance provides a measure of the center variation in mortality explained by center intervention rates after controlling for patient risk factors.
These models were derived for all infants and for the subgroups with GAs ,25 weeks and $25 weeks. All modeling analyses were performed by using the Xtmelogit command in Stata 12 (StataCorp, College Station, TX).
RESULTS
Wide ranges in intervention rates and mortality were observed among NRN centers for infants of all GAs as well as for those with GAs ,25 weeks and $25 weeks ( Table 2 , Fig 1) . The ranges of the intervention rates for infants with GA ,25 weeks were typically wider than those for infants with GA $25 weeks.
Our major estimation results from the multilevel models are summarized in the following paragraphs (Table 3) .
Infants of All GAs: Early Mortality
Model 2 indicates the intervention score had a significant association with center mortality (odds ratio [OR]: 0.79; 95% confidence interval [CI]: 0.74-0.84) and reduced the center mortality variance from 0.38 to 0.07. After controlling for patient risk factors in Models 3 and 4, the association of the intervention score remained significant (OR: 0.76; 95% CI: 0.67-0.86) and the mortality variance was reduced by from 0.64 to 0.27.
Infants of All GAs: In-Hospital Mortality
Before controlling for individual risk factors, the intervention score significantly reduced the odds of the overall The association of the intervention score was not statistically significant either before or after accounting for patient risk factors.
The mortality variance estimates from all models, in all subgroups of each outcome, after accounting for patient risk factors were significantly greater than zero. Thus, center variation in early and in-hospital mortality exists even after controlling for intervention rates and patient risk factors.
DISCUSSION
Our study yields a number of interesting points for consideration. First, it reveals that in the NRN, there was significant variation among centers in ELBW mortality. This result was true for both early and in-hospital mortality for each GA subset; it is shown in the observed center death rates and also by the significant center mortality variance estimates from Model 1, which did not include center interventions or patient risk factors, for each outcome and subgroup. Second, our modeling results cast doubt on the commonly held concept that variation in outcomes is due largely to differences in patient population. The center mortality variance estimates after correcting for patient risk factors (Model 3) were still significant for all outcomes and subgroups. Finally, center intervention rates predicted mortality outcomes and reduced differences in the outcomes among the centers. In deriving the intervention scores, interventions not generally given in the first 12 hours of life were excluded for the early mortality outcome. As indicated by the weighting factors used in the principal components analysis (Appendix 2), the intervention scores were primarily composed of the averages of the center intervention rates of NICU admission, respiratory support, supplemental oxygen, surfactant, and, for infants of ,25 weeks' GA, antenatal The range in the number of infants per center (n) is shown for each GA category.
corticosteroids, cesarean delivery, and tracheal intubation. The intervention scores showed significantly positive association with both early and inhospital mortality in the all-GA population and in the ,25-week GA subgroup, but they showed only a trend toward significance in the $25-week GA subgroup. In addition, the center mortality variance was greatly reduced when the intervention score was included in the models. These intervention scores reduced the mortality variance estimates substantially for both early and in-hospital mortality for the all-GA group, and in the ,25-week GA subgroup the reductions were even greater. This finding was true even after correction for patient risk factors. Therefore, a substantial number of additional infants would be predicted to survive both past 12 hours and until discharge should the utilization of the examined interventions be increased for infants at the earliest gestational ages (,25 weeks). One potential explanation for the finding that increased intervention is especially beneficial for infants with GA ,25 weeks concerns the wider range of the centers' use of supportive therapies in the intrapartum period and the first hours of life. In particular, there was large practice variation among centers in the use of antenatal corticosteroids, cesarean delivery, respiratory support, and NICU admission for these most premature infants. Our derived intervention score more effectively represents the specific intervention therapies examined among infants with GA ,25 weeks than among infants with GA $25 weeks. More research is needed to identify and determine other factors associated with mortality among infants with GA $25 weeks.
This study' s strengths include the use of high-quality data from the centers of the NRN collected by trained research staff applying standardized methods. The use of prospectively collected data has presumably limited the probability of selection bias and misclassification of covariates and outcomes. The use of the hierarchical modeling method allowed us to separate the effects of patient-and center-level variables and to assess the impacts of center-level variables both on mortality and on its variability among centers. Limitations of the study include the relatively small number of centers. Also, capturing all variability in care is unlikely given the limited number of elements in the NRN database, even after correcting for patient-level differences. Thus, some interventions or approaches not available in the NRN database may affect center mortality rates. This observational study reveals an association between interventions and survival, but intervention trials are required to demonstrate a true causal link between specific interventions and patient survival. Finally, our study was not able to examine variability in physician-level care within centers or the quality with which interventions were implemented, which are additional possible contributors to variation in outcome.
Our results show that even though aggressive intervention with more infants would increase survival, the use of the interventions we studied does not fully explain the center variation in mortality, which implies that there are unaccounted-for variables that affectthe center differences in mortality. Previous studies have postulated what these factors may be. Horbar et al 12 found that patient volume and the presence of a residency program were not predictive of outcomes. Rogowski et al 13 found that the percentage of Medicaid beneficiaries, type of hospital ownership, and presence of a teaching hospital were not significant predictors of outcomes. These investigators also found that very low volume centers had worse outcomes and that the outcome was related to the level of NICU. These findings do not explain the variation in mortality among NRN centers, which are all highvolume, high-level centers.
Our results suggest that decisions of whether to resuscitate very preterm infants affect mortality and are detectable at the center level. This observation raises ethical issues. However, creating clear policies on the appropriateness of resuscitating ELBW infants is extremely difficult, 15, 16 and a thorough examination of this topic is beyond the scope of this study. This report simply highlights that increased survival is possible, and the authors believe that decision makers (parents and physicians) should be aware of this fact. More aggressive intervention of these neonates would increase their likelihood of survival. The current study does not address the impact of more aggressive intervention on the likelihood of "intact" survival, ie, survival without major neurodevelopmental impairment, but this association has been shown in this network. 17 More active intervention of extremely preterm infants may benefit not only these infants but also more mature infants; centers in which intensive care is more frequently provided to extremely preterm infants have been shown to have better outcomes, too, for preterm infants of later gestation. 18 Neonatal care has been advanced by the development and testing of beneficial therapies. 19 It is important to note that the magnitude of the center effect on ELBW mortality is larger than the intervention effects of even the most potent therapies, such as antenatal corticosteroids and surfactant replacement therapy. This fact underscores the importance of stratification by center in all multicenter clinical trials in neonatology. The findings of our study support a role for comprehensive, well-designed, quality-improvement trials focusing on the care of very early GA infants.
CONCLUSIONS
There are large differences among centers in the mortality rate of extremely preterm infants. Patient characteristics do not adequately account for this variability. Center use of certain interventions predicts survival for the lowest GA infants, but it explains little of the observed variability in in-hospital mortality for infants born at $25 weeks. Some as-yet-unmeasured characteristics of the centers account for the remainder of the observed variability. The variation in mortality among centers may be reduced through standardization of care for very early GA infants. However, other center differences may explain the residual differences in mortality.
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APPENDIX 1: SPECIFICATIONS OF MULTILEVEL HIERARCHICAL MODELS
Denote the outcome variable by an indicator y ij , such that patient i in center j will die (y ij = 1) or survive (y ij = 0). Let a j be a random variable and u j be a normally distributed random-error term with a mean of 0 and an SD of s for center j. Let PC J be the principal components score from the center intervention rates with coefficients g 1 and x 1ij … x 9ij representing the 9 patient and maternal characteristics with corresponding coefficients (b 1 … b 0 ). The 4 model forms used for the probability of death, P(y ij = 1), are as follows.
Model 1
Patient-Level Model log ðP ðy ij Þ ¼ 1Þ
Model 3
Patient-Level Model log P ðy ij ¼ 1Þ
Center-Level Model
On the basis of the above models, the average center mortality rate and its range within 2 SDs (presented in Tables  2 and 3 ) can be computed as e g0 1 þ e g0 and the range as e g 0j 6 2s
1 þ e g 0j 6 2s
APPENDIX 2: COMPOSITION OF FIRST PRINCIPAL COMPONENTS OF CENTER INTERVENTION RATES
Principal components analysis is a method to reduce the number of variables under consideration. We have included as many as 15 types of interventions in this study. It is unrealistic to include all of these interventions simultaneously in the multilevel models, but we can try to derive an index from these intervention rates and use it as a predictor. The principal components generated from the intervention rates are such indices in the form of linear combinations oftheinterventionratesand can best represent the variation of these intervention rates among centers. A brief description of the method follows.
Let X represent a matrix in which each column contains the intervention rates for a center and b represent a standardized vector of the weighting factors in the linear combination of the intervention rates such that b9b = 1. For simplicity of notation, the intervention rates are deducted by their means so that they have a mean of 0. Then, linear combinations of the intervention rates can be represented for all centers as b9X.
A variance estimate of linear combination of the intervention rates will be as follows:
Note that XX9/(n 2 1) is a variance estimate of the intervention rates and often denoted by S. Principal components analysis produces a set of uncorrelated linear combinations whose variances, added together, are identical to that in S. Usually, they are ordered by their variances, and the proportion of variance to total variance indicates their relative importance. The first principal component that has the maximum variance is often of particular interest Those principal components with a small variance may be ignored.
The proportion of variance and the weighting factor b for the first principal component of the intervention rates for predicting early mortality and inhospital mortality are shown below. It can be seen that the proportion of variance is higher for the intervention rates for early mortality and much higher among infants with GA ,25 weeks. Also, these principal components are essentially an average of all center rates except for CPAP and epinephrine. The weighting factors for the center rates are nearly equal, but those for CPAP and epinephrine are close to zero. Similarly, the principal components score for in-hospital mortality is an average of all center rates except for CPAP, epinephrine, and prophylactic indomethacin.
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